Insider filing
Traded Feb 25 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jan 28, 2026 · Filed Jan 29, 2026
Charles Schwab's Co-Chairman sold $4.64M of Charles Schwab shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$4,640,092
Shares × reported transaction price
7 days after results of Jan 21, 2026, 78 days before results of Apr 16, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $103.47 on Jan 28, 2026, within 1% of its 52-week high, after a 7% rise over the previous 30 trading days
52-week range $69.06 (Apr 4, 2025) to $104.05 (Jan 22, 2026), 98% of the way up, from 251 adjusted closes. 30 trading days earlier: $96.65 on Dec 12, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 1 day before SCHW filed an 8-K: changed a top executive or board member, and shared information with investors (Jan 29, 2026)
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
A securities lawsuit naming the company as a defendant was filed on Oct 6, 2025 in the U.S. District Court, E.D. Texas. A filing is an allegation, not a finding.
2 such cases were open. Lewis v. Charles Schwab & Co., Inc., docket 4:25-cv-01086, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.4% | −2.4% | +0.9% |
| 30 days | −7.7% | −1.1% | −6.6% |
| 90 days | −11.9% | +2.5% | −14.4% |
| 180 days | +2.4% | +6.8% | −4.3% |
Past results only. Not a forecast.
Insider filing
Traded Feb 25 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Feb 25 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Dennis Howard (MD, Chief Tech, OPS & Data Off) sold ~$2.65M of Charles Schwab Corporation
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.